Assessment of the Quality of the Treatment of Atopic Dermatitis of the Face

Simple item page
dc.creatorMukumovich, Abdullaev Davlat
dc.date2023-02-28
dc.date.accessioned2023-08-21T09:05:51Z
dc.date.available2023-08-21T09:05:51Z
dc.descriptionthis article attempts to reveal the main reasons for the effectiveness and safety of the use of comfodermK cream (methylprednisolone aceponate 0.1%) and tacropic ointment 0.03% (tacrolimus 0.03%) for the treatment of manifestations of atopic dermatitis on the face. To carry out scientific work, the author evaluated the results of treatment was carried out in 12 patients, aged 6 to 13 years, with a diagnosis of atopic dermatitis, the childhood period was moderate. The problem in question is still little studied, therefore, requires more thorough research.en-US
dc.formatapplication/pdf
dc.identifierhttps://univerpubl.com/index.php/semantic/article/view/553
dc.identifier.urihttp://dspace.umsida.ac.id/handle/123456789/22195
dc.languageeng
dc.publisherUniver Publishingen-US
dc.relationhttps://univerpubl.com/index.php/semantic/article/view/553/462
dc.sourceWeb of Semantic: Universal Journal on Innovative Education; Vol. 2 No. 2 (2023): Web of Semantic: Universal Journal on Innovative Education; 170-173en-US
dc.source2835-3048
dc.subjectkomfodermKen-US
dc.subjecttacrolimusen-US
dc.subjectatopic dermatitisen-US
dc.titleAssessment of the Quality of the Treatment of Atopic Dermatitis of the Faceen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Articleen-US
Files
Collections
Web of Semantic: Universal Journal on Innovative Education